NCT03361345

Topical 5% Tranexamic Acid as a Treatment for Postinflammatory Hyperpigmentation Due to Acne Vulgaris

• Status: Withdrawn
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Wayne State University · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The goal of this study is to determine if topical tranexamic acid is capable of decreasing the pigment of the dark spots left from acne bumps. The first line medication used for this often is not tolerated well by patients, and topical tranexamic acid has minimal reported side effects thus far.

Conditions

• Postinflammatory Hyperpigmentation

Interventions

Type	Name	Description
DRUG	Tranexamic Acid	Topical tranexamic acid in cream form applied to dark spots on right side of face.
DRUG	Vehicle	The Vehicle is going to be a cream without any active medication that will be applied as a control substance for the topical tranexamic acid cream, and will be applied to the contralateral side of the face.

Timeline

• Start date: 2018-11-01
• Primary completion: 2022-01-09
• Completion: 2022-01-09
• First posted: 2017-12-04
• Last updated: 2023-05-16

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study